Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 5.02% is 212% above its 5-year average of -4.49%, near the high end of its 5-year range (-93.48%–26.09%).
As of the fiscal period ended Tuesday, March 31, 2026. 124.79% above its 12-month average of -20.24%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
5.02%
NET PROFIT MARGIN AVG TTM
-20.24%
NET PROFIT MARGIN AVG 3Y
-2.01%
NET PROFIT MARGIN AVG 5Y
-0.04%
NET PROFIT MARGIN AVG 10Y
1.55%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+124.79%
CURRENT VS 3Y AVG
+349.92%
CURRENT VS 5Y AVG
+11410.18%
CURRENT VS 10Y AVG
+223.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.59%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-41.61%
vs the sector median at left
Viatris Inc.
Market Cap
$20.55B
Net Profit Margin
5.02%
TTM Avg
-20.24%
3Y Avg
-2.01%
5Y Avg
-0.04%
Market Cap
$22.03B
Net Profit Margin
40.61%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$18.99B
Net Profit Margin
9.05%
TTM Avg
10.17%
3Y Avg
9.38%
5Y Avg
6.86%
Market Cap
$22.32B
Net Profit Margin
-141.43%
TTM Avg
-128.24%
3Y Avg
-70.25%
5Y Avg
-50.87%
Market Cap
$23.16B
Net Profit Margin
-44.73%
TTM Avg
-31.89%
3Y Avg
3.77%
5Y Avg
12.08%
Market Cap
$16.97B
Net Profit Margin
13.18%
TTM Avg
16.70%
3Y Avg
17.87%
5Y Avg
22.37%
Market Cap
$24.28B
Net Profit Margin
27.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$16.41B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viatris Inc. (VTRS) | $20.55B | 5.02% | -20.24% | -2.01% | -0.04% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 40.61% | 41.73% | 40.84% | 37.71% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.99B | 9.05% | 10.17% | 9.38% | 6.86% |
| Moderna, Inc. (MRNA)vs › | $22.32B | -141.43% | -128.24% | -70.25% | -50.87% |
| STERIS plc (STE)vs › | $22.68B | 13.18% | 12.25% | 8.55% | 8.79% |
| BioNTech SE (BNTX)vs › | $23.16B | -44.73% | -31.89% | 3.77% | 12.08% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 13.18% | 16.70% | 17.87% | 22.37% |
| Incyte Corporation (INCY)vs › | $24.28B | 27.71% | 12.90% | 13.00% | 12.11% |
| Medpace Holdings, Inc. (MEDP)vs › | $16.41B | 17.67% | 18.50% | 17.20% | 16.74% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 16.98% | 16.55% | 18.38% | 18.84% |
Operating Margin
-18.6%
Net Profit Margin
5.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 5.02% |
| 2025-12-31 | -9.18% |
| 2025-09-30 | -3.41% |
| 2025-06-30 | -0.13% |
| 2025-03-31 | -93.48% |
| 2024-12-31 | -14.64% |
| 2024-09-30 | 2.53% |
| 2024-06-30 | -8.60% |
| 2024-03-31 | 3.11% |
| 2023-12-31 | -19.95% |
| 2023-09-30 | 8.41% |
| 2023-06-30 | 6.74% |
| 2023-03-31 | 6.03% |
| 2022-12-31 | 26.09% |
| 2022-09-30 | 8.69% |
| 2022-06-30 | 7.62% |
| 2022-03-31 | 9.52% |
| 2021-12-31 | -6.08% |
| 2021-09-30 | 6.87% |
| 2021-06-30 | -6.10% |
| 2021-03-31 | -23.42% |
| 2020-12-31 | -25.27% |
| 2020-09-27 | 6.25% |
| 2020-06-28 | 1.44% |
| 2020-03-29 | 0.79% |
| 2019-12-31 | 0.64% |
| 2019-09-29 | 6.41% |
| 2019-06-29 | -5.91% |
| 2019-03-30 | -1.00% |
| 2018-12-30 | 1.66% |
| 2018-09-29 | 6.17% |
| 2018-06-29 | 1.34% |
| 2018-03-30 | 3.24% |
| 2017-12-30 | 7.54% |
| 2017-09-29 | 2.96% |
| 2017-06-29 | 10.03% |
| 2017-03-30 | 2.44% |
| 2016-12-30 | 12.78% |
| 2016-09-29 | -3.92% |
| 2016-06-29 | 6.58% |
| 2016-03-30 | 0.63% |
| 2015-12-30 | 7.81% |
| 2015-09-29 | 15.90% |
| 2015-06-29 | 7.08% |
| 2015-03-30 | 3.02% |
| 2014-12-30 | 9.08% |
| 2014-09-29 | 23.95% |
| 2014-06-29 | 6.81% |
| 2014-03-30 | 6.76% |
| 2013-12-30 | 9.96% |
| 2013-09-29 | 8.99% |
